Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma.
Rosa NguyenArdiana MoustakiJacqueline L NorrieShantel BrownWalter J AkersAbbas ShirinifardMichael A DyerPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
The substitution of IL15 for IL2 leads to significant tumor regression in vitro and in vivo and supports clinical testing of IL15 for immunotherapy in pediatric neuroblastoma.
Keyphrases